That doesn't mean they don't seem to be thinking about it. A number of breakthrough therapy designations have been granted for psilocybin during the treatment of resistant depression—that's, depression that does not reply to at the least two different types of antidepressants—and also a broader acceptance could be around the horizon.Outside of